References
- Sadove MS, Balagot RC, Hatano S, et al. Study of a narcotic antagonist-N-allyl-noroxymorphone. JAMA. 1963;183:666–668.
- Naloxone Hydrochloride Injection. Prescribing information. Lake Forest, IL: Hospira, Inc. [updated Jan 2018]. Available from: https://dailymed.nlm.nih.gov/dailymed/
- Connors NJ, Nelson LS. The evolution of recommended naloxone dosing for opioid overdose by medical specialty. J Med Toxicol. 2016;12:276–281.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
- Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review. Expert Opin Drug Saf. 2015;14:1137–1146.
- Olofsen E, van Dorp E, Teppema L, et al. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic–pharmacodynamic modeling study. Anesthesiology. 2010;112:1417–1427.
- von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.
- Christenson J, Etherington J, Grafstein E, et al. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med. 2000;7:1110–1118.
- Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660–667.
- Wanger K, Brough L, MacMillan I, et al. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med. 1998;5:293–299.
- Watson WA, Steele MT, Muelleman RL, et al. Opioid toxicity recurrence after an initial response to naloxone. J Toxicol Clin Toxicol. 1998;36:11–17.
- Kim HK, Nelson LS. Reversal of opioid-induced ventilatory depression using low-dose naloxone (0.04 mg): a case series. J Med Toxicol. 2016;12:107–110.